Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.

about

Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.

P2860

Q52629217-CEC62533-3490-4823-ACF1-CD2C7F0D94F6

P2860

Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.

Item

http://www.wikidata.org/entity/Q40113860

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Treatment outcome of patients ...... spective multicenter analysis.

@en

type

Item

label

Treatment outcome of patients ...... spective multicenter analysis.

@en

prefLabel

Treatment outcome of patients ...... spective multicenter analysis.

@en

P1476

Treatment outcome of patients ...... ospective multicenter analysis

@en

P2093

Anna M E Bruynzeel

http://www.w3.org/2001/XMLSchema#string

Annemiek M E Walenkamp

http://www.w3.org/2001/XMLSchema#string

Henk M W Verheul

http://www.w3.org/2001/XMLSchema#string

Hiske L van der Weide

http://www.w3.org/2001/XMLSchema#string

Jaap C Reijneveld

http://www.w3.org/2001/XMLSchema#string

Michiel Wagemakers

http://www.w3.org/2001/XMLSchema#string

Myra E van Linde

http://www.w3.org/2001/XMLSchema#string

Peter M van de Ven

http://www.w3.org/2001/XMLSchema#string

Roelien H Enting

http://www.w3.org/2001/XMLSchema#string

W Peter Vandertop

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 and IDH2 mutations in gliomas

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

P2888

s11060-017-2564-z

P304

183-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2564-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

Philip C De Witt Hamer

Cyrillo G Brahm

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090832587

http://www.w3.org/2001/XMLSchema#string

P698

28730289

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

5658463

http://www.w3.org/2001/XMLSchema#string

Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.

about

P2860

P2860

Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932